August 31, 2026

Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth Prospects Amidst a Dynamic Market

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector, operates at the forefront of genetic and genomic analysis. With a market capitalization of $32.55 billion, the company is a..

Incyte Corporation (INCY) Stock Analysis: A Biotech Leader with 37.7% Revenue Growth and Promising Pipeline

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, has attracted investor attention with its impressive 37.7% revenue growth and robust product pipeline. As a biopharmaceutical company focused..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a Healthcare Tech Leader with Diverse Strategic Collaborations

Tempus AI, Inc. (NASDAQ: TEM) stands as a formidable player in the healthcare technology sector, characterized by its innovative approach and robust collaborations with industry giants. With a market cap..

United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating a 28.88% Upside Potential in the Healthcare Sector

For investors eyeing the healthcare sector, United Therapeutics Corporation (NASDAQ: UTHR) presents an intriguing opportunity with a notable potential upside of 28.88%, as suggested by current analyst ratings. As a..

Neurocrine Biosciences, Inc. (NBIX)

⚠️ No article content returned.

..

Amgen Inc. (AMGN) Stock Analysis: Navigating a 91.47% Return on Equity Amidst Market Volatility

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, remains a focal point for investors seeking exposure to the drug manufacturing industry. With a market capitalization of $233.78 billion,..

Tenet Healthcare Corporation (THC) Stock Analysis: A Strong Buy with 6.86% Upside Potential

Tenet Healthcare Corporation (NYSE: THC) is garnering significant attention in the investment community, and for good reason. With a market capitalization of $21.48 billion, Tenet stands as a formidable player..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 16.20% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a major player in the healthcare sector specializing in medical devices, has been attracting attention among investors with its expansive product offerings and..

IQVIA Holdings (IQV) Stock Analysis: Navigating Growth in the Healthcare Sector

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, is capturing investor attention with its robust market positioning and strategic growth initiatives. Operating in the diagnostics and research..

Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings Signal Potential Upside in Diagnostics Sector

Labcorp Holdings Inc. (NYSE: LH) stands out in the healthcare sector, particularly within the diagnostics and research industry. With a significant market capitalization of $27.18 billion, Labcorp is a formidable..

Biogen Inc. (BIIB) Stock Report: Analyst Ratings Signal Potential Upside of Over 8%

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, stands as a beacon in the general drug manufacturing industry, boasting a robust market capitalization of $32.28 billion. With..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Assessing a Potential 107.71% Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT) is carving its niche in the biotechnology sector with a focus on developing innovative therapies, including its lead candidate, ivonescimab, targeting non-small lung cancer (NSCLC)..

Teva Pharmaceutical Industries (TEVA): Investor Outlook with a 13.61% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector, stands as a beacon for investors seeking exposure to the robust yet volatile world of pharmaceutical manufacturing. As..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings and a Promising 3.63% Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, has been making significant waves with its innovative continuous glucose monitoring (CGM) systems. Based in San..

Natera, Inc. (NTRA) Stock Analysis: A Healthcare Powerhouse with a 3.21% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a leading player in the Healthcare sector’s Diagnostics & Research industry, has been making headlines with its cutting-edge molecular testing services. With a market capitalization of..

Boston Scientific Corporation (BSX) Investor Outlook: Impressive 33.84% Potential Upside Amid Strong Buy Ratings

Boston Scientific Corporation (BSX), a stalwart in the medical devices industry, continues to capture investor interest with its robust market position and promising growth prospects. With a market capitalization of..

STERIS plc (STE) Stock Analysis: Understanding the 12.55% Upside Potential

Investors looking for robust opportunities in the healthcare sector might find STERIS plc (NYSE: STE) an intriguing prospect. With a market capitalization of $22.79 billion, STERIS plc is a prominent..

Merck & Company, Inc. (MRK) Stock Analysis: Is the Current Valuation Justified for Investors?

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization of $366 billion, Merck..

Alcon Inc. (ALC) Stock Analysis: A Closer Look at Its 18.37% Potential Upside

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, continues to capture investor attention with its robust market positioning and..

argenx SE (ARGX) Investor Outlook: Analyzing the 14.89% Potential Upside in Biotechnology

In the dynamic world of biotechnology, argenx SE (NASDAQ: ARGX) stands as a formidable player, captivating investor attention with its promising growth prospects and impressive market performance. With a current..

Search

Funds

August 31, 2026

Search

Funds

August 31, 2026

FTSE 100

Funds